|
1997 Two of the future founders met at EPFL while working for their PhD theses. They were introduced to a senior business coach who was sponsoring start-up projects in the visual communication domain. All three then cooperated in the creation of a future business.
2000 Developing their idea of using digital imaging for document protection, the founders filed the first patent of Cryptoglyph, the core AlpVision security printing solution for both brand and document protection.
2001 The three founders established the first legal status of AlpVision as a limited liability company with an initial share capital of 20’000 CHF.
2002 A private business angel agreed to support the founders. The share capital was raised to CHF 620’000 allowing the company to further develop both the Cryptoglyph technology and the first contacts with prospective customers. The legal identity was changed to a privately owned limited company.
2003 The company broke even and then showed a net profit at the end of the fiscal year, resulting from the first contracts signed with clients for brand protection, document protection and custom solutions. These three domains then became the core business units of the company. Since 2003 the company’s growth rate has exceeded 30% per year.
2004 The company gained a reputation as a very promising business in worldwide markets, collecting awards such as the European Seal of Excellence and the Swiss Economics awards (CTI /KTI label).
2005 The Company passed the psychological barrier of one million U.S.dollars of net earnings after tax, interest and amortization, an 88% increase over 2004, paving the way for successful internally financed development of its activities worldwide.
2006 The company obtained the Swiss Quality Label for its products and services delivered worldwide. The turnover of the company increased by 35% compared to 2005, with major deployments of its Cryptoglyph brand protection solution in the Fast Moving Consumer Goods industry.
2007 The AlpVision Krypsos™ Web application for management of global anti-counterfeiting programs successfully passed the FDA 21 CFR Part 11 requirements for Electronic Records (ERES) regarding medicines delivered in the USA. The company achieved a 42% increase in turnover compared to 2006.
2008 AlpVision continued to grow its turnover with new clients in the pharmaceutical industry. The head office space was doubled to house the significant increase of the payroll.
2009 Fingerprint™ new on-product protection solution for plastic molded parts was successfully deployed at industrial level for protection of millions of items worldwide.
|